Release Date: 25/05/10 12:24 Summary: Amended Appendix 3Y Price Sensitive: No Download Document 20.43KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%